The conflict, sparked by U.S. and Israeli attacks on Iran two weeks ago and broadened by Iranian strikes around the region, ...
Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...
A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...
A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...
InvestorsHub on MSN
CytomX highlights clinical progress for lead cancer drug in Q4 update
CytomX Therapeutics Inc. (NASDAQ:CTMX) used its fourth-quarter 2025 earnings call to highlight progress in the clinical ...
Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells. Michael S.
The FDA's cancer advisors will discuss AstraZeneca’s application for the oral SERD camizestrant in breast cancer and the AKT ...
Engineers at Duke University have demonstrated a technique that uses microbubbles and ultrasound to help relatively large ...
Engineers at Duke University have demonstrated a technique that uses microbubbles and ultrasound to help relatively large cancer drugs enter tumor cells and cause them to self-destruct.
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results